Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Virtual park ride could boost rehab motivation for brain conditions

NCT ID NCT07616050

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using a virtual reality (VR) system during cycling exercise makes rehabilitation more motivating for adults with conditions like stroke, Parkinson's, multiple sclerosis, or frailty. About 70 participants will try cycling with and without VR over 4 weeks. The goal is to see if the VR approach improves motivation, enjoyment, and usability compared to standard cycling.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Informed consent to the study * subjects \> 18 years and \<85 years * diagnosis of MCI according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders VTh Edition (DSM V TR American Psychological Association 2013) * detection of ischemic stroke within 6 months preceding the study, frail elderly subjects (Gobbens RJ et al. 2010) * subjects affected by idiopathic Parkinson's disease according to the MDS-PD criteria (Postuma et al., 2015) * subjects affected by possible, probable and definite ALS according to the revised El Escorial criteria (Brooks Br, et al. 2000) * subjects affected by MS according to the McDonald criteria (2017) with disability measured with the EDSS (Expanded Disability Status Scale) \<= 8 * patients with spinal cord injury of different etiology with incomplete spinal cord injury, AIS (ASIA impairment scale) grade C and D, MMSE \>18 * subjects naïve to the use of the RV * no therapeutic changes or rehabilitation interventions in the month prior to inclusion in the study * no ongoing behavioral disorders. Exclusion Criteria: * Other concomitant neurological pathologies in addition to the one under study * presence of visual disturbances that do not allow access to the experimental virtual reality protocol * presence of impaired cardiorespiratory function or other organic instabilities that contraindicate ergometer training * severe osteoporosis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Amyotrophic lateral sclerosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    7 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centro di Riabilitazione Villa Beretta

    Costa Masnaga, Lecco, 23845, Italy

  • Istituti a Carattere Scientifico Maugeri Bari

    Bari, Bari, 70124, Italy

  • Istituti a Carattere Scientifico Maugeri Milano Camaldoli

    Milan, Milano, 20138, Italy

  • Istituti a Carattere Scientifico Maugeri Montescano

    Montescano, Pavia, 27040, Italy

  • Istituti a Carattere Scientifico Maugeri Pavia

    Pavia, Pavia, 27100, Italy

  • Istituti a Carattere Scientifico Maugeri Telese

    Telese Terme, Benevento, 82037, Italy

  • Università di Pisa

    Pisa, Pisa, 56126, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.